Europe — EMA
Albúmina Humana Csl Behring (Human Plasma Protein)
Albúmina Humana Csl Behring is a human plasma protein used for intravenous administration. It is commonly used to treat conditions related to low protein levels
Request sourcing
What is Human Plasma Protein?
Albúmina Humana Csl Behring is a human plasma protein used for intravenous administration. It is commonly used to treat conditions related to low protein levels in the blood.
What is Human Plasma Protein used for?
Albúmina Humana Csl Behring is primarily used to increase plasma volume and treat conditions associated with low protein levels. It is often administered to patients who have experienced significant blood loss or are undergoing surgery. This medication helps to maintain proper blood pressure and circulation.
What are the side effects of Human Plasma Protein?
Common effects of Albúmina Humana Csl Behring may include improved blood volume and circulation. Patients might experience a reduction in symptoms related to low protein levels, such as swelling and fatigue. However, individual responses can vary.
What precautions apply to Human Plasma Protein?
Albúmina Humana Csl Behring should be administered under medical supervision. Patients with known allergies to human plasma proteins should exercise caution. It is important to follow proper handling and storage guidelines to ensure safety and efficacy.
What does Human Plasma Protein interact with?
Albúmina Humana Csl Behring may interact with certain medications, particularly those that affect blood pressure or circulation. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.



